These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 18710626

  • 1. [Correlation of fever to infection in patients with chemotherapy-induced neutropenia].
    Ruan YP, Zhang WY.
    Ai Zheng; 2008 Aug; 27(8):879-81. PubMed ID: 18710626
    [Abstract] [Full Text] [Related]

  • 2. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.
    Minisini A, Spazzapan S, Crivellari D, Aapro M, Biganzoli L.
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):125-31. PubMed ID: 15661563
    [Abstract] [Full Text] [Related]

  • 3. The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer.
    Banerji U, Ashley S, Coward J, Hughes S, Zee Y, Benepal T, Norton A, Eisen T, O'Brien M.
    Lung Cancer; 2006 Dec; 54(3):371-7. PubMed ID: 17049670
    [Abstract] [Full Text] [Related]

  • 4. Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer.
    Sharma S, Rezai K, Driscoll D, Odunsi K, Lele S.
    Gynecol Oncol; 2006 Oct; 103(1):181-5. PubMed ID: 16574203
    [Abstract] [Full Text] [Related]

  • 5. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
    Borg C, Ray-Coquard I, Philip I, Clapisson G, Bendriss-Vermare N, Menetrier-Caux C, Sebban C, Biron P, Blay JY.
    Cancer; 2004 Dec 01; 101(11):2675-80. PubMed ID: 15503313
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 01; 28(3):339-44. PubMed ID: 16900629
    [Abstract] [Full Text] [Related]

  • 7. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M, Thamlikitkul V.
    J Med Assoc Thai; 2003 Mar 01; 86(3):212-23. PubMed ID: 12757060
    [Abstract] [Full Text] [Related]

  • 8. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, Bootsma GP, Tjan-Heijnen VC.
    J Clin Oncol; 2005 Nov 01; 23(31):7974-84. PubMed ID: 16258098
    [Abstract] [Full Text] [Related]

  • 9. [Fever profile of febrile neutropenia in patients treated with cancer chemotherapy for hematological malignancies].
    Tamai Y, Imataki O, Kawakami K.
    Gan To Kagaku Ryoho; 2010 May 01; 37(5):859-62. PubMed ID: 20495316
    [Abstract] [Full Text] [Related]

  • 10. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS, Sen R, Dixit G.
    J Assoc Physicians India; 2008 Dec 01; 56():942-4. PubMed ID: 19322972
    [Abstract] [Full Text] [Related]

  • 11. [Randomized controlled study of leucomax (recombinant human granulocyte-macrophage colony stimulating factor, rhGM-CSF) in the treatment of cancer chemotherapy-induced leucopenia].
    Feng F, Zhou L.
    Zhonghua Zhong Liu Za Zhi; 1998 Nov 01; 20(6):451-3. PubMed ID: 10920943
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic risk factors for serious complications in an inpatient population with neutropenia at the onset of a febrile episode].
    Gómez Roca C, Rivero M, Hugo K, Novillo A, Marta Lapadula M, Recondo G, Milberg M.
    Medicina (B Aires); 2006 Nov 01; 66(5):385-91. PubMed ID: 17137166
    [Abstract] [Full Text] [Related]

  • 13. Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model.
    Dranitsaris G, Rayson D, Vincent M, Chang J, Gelmon K, Sandor D, Reardon G.
    Am J Clin Oncol; 2008 Aug 01; 31(4):369-74. PubMed ID: 18845996
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR.
    J Clin Oncol; 2004 Aug 15; 22(16):3350-6. PubMed ID: 15310780
    [Abstract] [Full Text] [Related]

  • 15. A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.
    Yamamoto N, Sekine I, Nakagawa K, Takada M, Fukuoka M, Tanigawara Y, Saijo N.
    Jpn J Clin Oncol; 2009 Jul 15; 39(7):425-30. PubMed ID: 19395467
    [Abstract] [Full Text] [Related]

  • 16. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Lyman GH, Delgado DJ.
    Cancer; 2003 Dec 01; 98(11):2402-9. PubMed ID: 14635075
    [Abstract] [Full Text] [Related]

  • 17. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy.
    Caggiano V, Weiss RV, Rickert TS, Linde-Zwirble WT.
    Cancer; 2005 May 01; 103(9):1916-24. PubMed ID: 15751024
    [Abstract] [Full Text] [Related]

  • 18. Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.
    Gillis S, Dann EJ, Rund D.
    Am J Hematol; 1996 Jan 01; 51(1):26-31. PubMed ID: 8571934
    [Abstract] [Full Text] [Related]

  • 19. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G, Fountzilas G, Kalofonos HP, Golfinopoulos V, Aravantinos G, Bafaloukos D, Papakostas P, Pectasides D, Christodoulou C, Syrigos K, Economopoulos T, Pavlidis N, Hellenic Cooperative Oncology Group.
    Crit Rev Oncol Hematol; 2008 Jun 01; 66(3):237-47. PubMed ID: 18243010
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A, Saito H, Toyama K, Horiuchi A, Kuriya S, Furusawa S, Tsuruoka N, Takiguchi T, Matsuda T, Utsumi M, Shiku H, Matsui T, Egami K, Tamura K, Ohno R.
    Int J Hematol; 2000 Feb 01; 71(2):136-43. PubMed ID: 10745623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.